L. Arthur Hewitt
Nessuna posizione attualmente
Profilo
L.
Arthur Hewitt worked as a Director of Scientific Affairs at Shearwater Corp.
in 2002-2003, and at Amgen Canada, Inc. in 2000.
He was also a Vice President of Drug Development at Ivory Capital Corp.
in 2005.
From 2011 to 2014, he served as the Chief Scientific Officer and Vice President at Chelsea Therapeutics International Ltd.
Hewitt holds a doctorate degree from the University of Montréal.
Precedenti posizioni note di L. Arthur Hewitt
| Società | Posizione | Fine |
|---|---|---|
| CHELSEA THERAPEUTICS INTERNATIONAL LTD. | Direttore Tecnico/Scientifico/R&S | 23/06/2014 |
| Ivory Capital Corp. | Corporate Officer/Principal | 02/08/2005 |
Shearwater Corp.
 Shearwater Corp. Pharmaceuticals: MajorHealth Technology Part of Nektar Therapeutics, Shearwater Corp. is a company that provides research services focused on health care applications of advanced PEGylation. The company is based in Huntsville, AL. The company was founded by James R. Hudson, J. Milton Harris. Shearwater was acquired by Nektar Therapeutics on July 02, 2001 for $164.50 million. | Direttore Tecnico/Scientifico/R&S | 01/01/2003 |
Amgen Canada, Inc.
 Amgen Canada, Inc. BiotechnologyHealth Technology Amgen Canada, Inc. operates as a biotechnology company. The company was founded in 1991 and is headquartered in Mississauga, Canada. | Direttore Tecnico/Scientifico/R&S | 10/01/2000 |
Formazione di L. Arthur Hewitt
| University of Montréal | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
| Ivory Capital Corp. | Finance |
Chelsea Therapeutics International Ltd.
 Chelsea Therapeutics International Ltd. BiotechnologyHealth Technology Chelsea Therapeutics International Ltd. acquires, develops and commercializes innovative products for the treatment of a variety of human diseases. The company was founded by Simon C. Pedder on June 17, 2005 and is headquartered in Charlotte, NC. | Health Technology |
Shearwater Corp.
Shearwater Corp. Pharmaceuticals: MajorHealth Technology Part of Nektar Therapeutics, Shearwater Corp. is a company that provides research services focused on health care applications of advanced PEGylation. The company is based in Huntsville, AL. The company was founded by James R. Hudson, J. Milton Harris. Shearwater was acquired by Nektar Therapeutics on July 02, 2001 for $164.50 million. | Health Technology |
Amgen Canada, Inc.
Amgen Canada, Inc. BiotechnologyHealth Technology Amgen Canada, Inc. operates as a biotechnology company. The company was founded in 1991 and is headquartered in Mississauga, Canada. | Health Technology |
- Borsa valori
- Insiders
- L. Arthur Hewitt
